Rigel Pharma (RIGL) – Analyst EPS Change
-
Rigel Pharma (RIGL) PT Raised To $9 At Citi After fostamatinib EU Deal Comes Early
-
Rigel Pharmaceuticals (RIGL) PT Raised to $5 at BMO Capital; Tavalisse NDA Filing Accepted, Improves Probability of Success to 80%
-
-
Back to RIGL Stock Lookup